ERICA NEWTON: Open Payments
NPI 1306212311 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 70 payments from 17 companies in 2025. Trend: 2023 $1,300 · 2024 $2,445 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $360 |
| ViiV Healthcare Company | 9 | $280 |
| Exact Sciences Corporation | 5 | $110 |
| Gilead Sciences, Inc. | 5 | $109 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Novo Nordisk Inc | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Amgen Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
Products named: DOVATO, VRAYLAR, AREXVY, CAPLYTA, The Cologuard Plus Collection Kit, JARDIANCE, BREZTRI, QULIPTA.
Industry payments across NY — which companies pay providers there.
